» Articles » PMID: 33804793

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know?

Overview
Journal Animals (Basel)
Date 2021 Apr 3
PMID 33804793
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

As cannabis-derived products have become more available, veterinarians are seeing more cases of toxicosis. In addition, animal owners are having an increasing interest in using these products for their pets. This review looks at the situation in Europe and North America, the different types of cannabis and cannabis-derived products with historical examples of use in animals, and the cannabis industry. The existing regulatory framework for use in humans and animals as medicines and/or supplements was examined. Finally, a review of the clinical indications for which medicinal cannabis is authorised, a discussion of toxicosis, and recommendations and warnings around medical cannabis use are presented.

Citing Articles

Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis.

Aragona F, Tabbi M, Gugliandolo E, Giannetto C, DAngelo F, Fazio F Front Vet Sci. 2024; 11:1496473.

PMID: 39720409 PMC: 11668182. DOI: 10.3389/fvets.2024.1496473.


Case report: Treatment of non-medical tetrahydrocannabinol toxicosis with transmucosal cannabidiol-infused dissolving sheets in six dogs.

Marsigliano K, Green K, DiGangi B Front Vet Sci. 2024; 11:1448123.

PMID: 39720406 PMC: 11667118. DOI: 10.3389/fvets.2024.1448123.


Investigating the effect a single dose of cannabidiol has on measures of stress in cats when being transported in a carrier and meeting a novel person in an unfamiliar environment.

Weller J, Flint H, Hunt A, Ellerby Z, King T Front Vet Sci. 2024; 11:1476296.

PMID: 39559539 PMC: 11571322. DOI: 10.3389/fvets.2024.1476296.


Use of Cannabidiol-Dominant Extract as Co-Adjuvant Therapy for Type 2 Diabetes Mellitus Treatment in Feline: Case Report.

Massabo J, Puiatti G, Ferrero P Med Cannabis Cannabinoids. 2024; 7(1):206-212.

PMID: 39474238 PMC: 11521493. DOI: 10.1159/000541034.


in veterinary medicine: Foundations and therapeutic applications.

Pinto K, Requicha J Can Vet J. 2024; 65(9):948-958.

PMID: 39219599 PMC: 11339888.


References
1.
Verrico C, Wesson S, Konduri V, Hofferek C, Vazquez-Perez J, Blair E . A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain. 2020; 161(9):2191-2202. PMC: 7584779. DOI: 10.1097/j.pain.0000000000001896. View

2.
Graham J, Li D . Cardiovascular and respiratory effects of cannabis in cat and rat. Br J Pharmacol. 1973; 49(1):1-10. PMC: 1776461. View

3.
Gamble L, Boesch J, Frye C, Schwark W, Mann S, Wolfe L . Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Front Vet Sci. 2018; 5:165. PMC: 6065210. DOI: 10.3389/fvets.2018.00165. View

4.
Crippa J, Zuardi A, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P . Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009; 24(7):515-23. DOI: 10.1002/hup.1048. View

5.
Birnbaum A, Karanam A, Marino S, Barkley C, Remmel R, Roslawski M . Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia. 2019; 60(8):1586-1592. DOI: 10.1111/epi.16093. View